Table 2. Serum IgE and eosinophil count before and after 2 months of mepolizumab treatment.
Case | IgE & Eos | Pre | 2 Months |
---|---|---|---|
1 | IgE (IU/mL) | 1,770 | 1,815 |
Eos (/μL) | 440 | 30 | |
2 | IgE (IU/mL) | 948 | 1,070 |
Eos (/μL) | 371 | 50 | |
3 | IgE (IU/mL) | - | - |
Eos (/μL) | 252 | 39 |
IgE was not measured in case 3 because of possible influence of omalizumab.
Eos, eosinophils.